Task: Answer the multiple-choice question.
Query: Which drug exhibits a -1.225\% hERG inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a) Oc1nc(-c2ccc(Cl)cc2)n2ccncc12
b) Cc1ccc(NC(=O)N2CCCC2C(=O)Nc2ccc(-n3cnnn3)c(C)c2)cc1
c) COCCCNc1nc2c(c(=O)n(C)c(=O)n2C)n1Cc1cccc(OC)c1
d) Cn1cccc1Cc1nnc(SCC(=O)NC2CCCC2)n1CCc1ccccc1
e) COc1ccc(C(=O)N2CCN=C2SCc2cccnc2)cc1OC
Answer: b. Cc1ccc(NC(=O)N2CCCC2C(=O)Nc2ccc(-n3cnnn3)c(C)c2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
1-N-(4-methylphenyl)-2-N-[3-methyl-4-(tetrazol-1-yl)phenyl]pyrrolidine-1,2-dicarboxamide